Ted Dobos joins Newfront as Private Equity Group Leader to Deliver Unmatched Value for Clients in M&A Transactions
SAN FRANCISCO, Jan. 19, 2022 – Newfront, the tech-driven insurance brokerage based in San Francisco, announced that Ted Dobos has joined to lead its Private Equity Group (PEG). The Private Equity Group will act as an extension of private equity deal teams while leveraging Newfront’s advanced analytics technology, delivering superior service and rapid actionable insights to maximize deal value.
Dobos, a leader in complex merger and acquisition risk, brings more than 25 years of experience in business intelligence, software solutions, finance, and insurance to the Private Equity Group.
“With Ted Dobos leading our Private Equity Group and our team of industry veterans, we are bringing Newfront’s private equity clients the best experience in the transactional risk space along with some of the most advanced risk analytics in the industry,” said Spike Lipkin, co-founder and CEO of Newfront. “With Ted’s direction, Newfront will be an even more powerful and effective partner managing the complexities of M&A risks for our clients.”
Newfront’s technology will enhance deal workflows and facilitate early insight on transaction risks that impact deal dynamics.
About the author
A Better Day Starts Here
Newfront is transforming the delivery of risk management, employee experience, insurance, and retirement solutions by building the modern insurance platform. Transparent data delivered real-time translates into a lower total cost of risk and greater insights. Newfront makes insurance work for you.
The information provided is of a general nature and an educational resource. It is not intended to provide advice or address the situation of any particular individual or entity. Any recipient shall be responsible for the use to which it puts this document. Newfront shall have no liability for the information provided. While care has been taken to produce this document, Newfront does not warrant, represent or guarantee the completeness, accuracy, adequacy, or fitness with respect to the information contained in this document. The information provided does not reflect new circumstances, or additional regulatory and legal changes. The issues addressed may have legal, financial, and health implications, and we recommend you speak to your legal, financial, and health advisors before acting on any of the information provided.